For the quarter ending 2026-03-31, NNVC has $10,219,004 in assets. $3,213,256 in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 3,213,256 | 5,150,580 | 1,125,711 | 1,558,564 |
| Prepaid expenses | 164,656 | 145,985 | 126,855 | 112,146 |
| Total current assets | 3,377,912 | 5,296,565 | 1,252,566 | 1,670,710 |
| Property and equipment, net | 6,528,873 | 6,656,439 | 6,787,456 | 6,833,891 |
| Intangible assets, total | - | 458,954 | 458,954 | 458,954 |
| Less accumulated amortization | - | 146,050 | 143,983 | 141,915 |
| Intangible assets, net | 310,836 | 312,904 | 314,971 | 317,039 |
| Service agreements | 1,383 | 1,732 | 2,087 | 2,445 |
| Total assets | 10,219,004 | 12,267,640 | 8,357,080 | 8,824,085 |
| Accounts payable-Nonrelated Party | 134,871 | 218,313 | 254,943 | 459,094 |
| Accounts payable-Related Party | 904,690 | 929,232 | 901,143 | 821,456 |
| Accrued expenses | 25,846 | 48,380 | 26,300 | 25,969 |
| Total current liabilities | 1,065,407 | 1,195,925 | 1,182,386 | 1,306,519 |
| Series a convertible preferred stock, 0.00001 par value, 10,000,000 shares designated, 918,422 and 905,717 shares issued and outstanding, at march 31, 2026 and june 30, 2025, respectively | 9 | 9 | 9 | 9 |
| Common stock, 0.00001 par value 150,000,000 shares authorized, 21,646,776 and 16,606,832 shares issued and outstanding, at march 31, 2026 and june 30, 2025, respectively | 216 | 216 | 176 | 166 |
| Additional paid-in capital | 163,990,343 | 163,919,128 | 157,801,428 | 156,359,252 |
| Accumulated deficit | -154,836,971 | -152,847,638 | -150,626,919 | -148,841,861 |
| Total stockholders' equity | 9,153,597 | 11,071,715 | 7,174,694 | 7,517,566 |
| Total liabilities and stockholders' equity | 10,219,004 | 12,267,640 | 8,357,080 | 8,824,085 |
NANOVIRICIDES, INC. (NNVC)
NANOVIRICIDES, INC. (NNVC)